MergerLinks Header Logo

Request Deal Involvement

Nestle Health Science completed the acquisition of the remaining 74.4% stake in Aimmune Therapeutics for c. $2bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

JP Morgan

financial advisors

JP Morgan

Latham & Watkins

legal advisors

Latham & Watkins

Lazard

financial advisors

Lazard

Davis Polk & Wardwell

legal advisors to financial advisors

Davis Polk & Wardwell

W2O Group

pr advisors

W2O Group

Bank of America

financial advisors

Bank of America

Mayer Brown

legal advisors

Mayer Brown

A&L Goodbody

legal advisors

A&L Goodbody

or

Principals

AIMMUNE THERAPEUTICS INC

target

AIMMUNE THERAPEUTICS INC

NESTLE HEALTH SCIENCE

bidder

NESTLE HEALTH SCIENCE

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite